Category Archives: technology and pharmaceutical costs

Taxes on Drug and Device Companies Removed in Repeal Plan: Insurers and Health Care Industry Concerns

Repeal proposes cutting taxes on Pharmaceutical and Medical Devise Companies while raising costs for elderly and those with pre-existing conditions.  The CEO of Blue Cross of California opposes current reform proposals, citing cost increases for individuals and families and harm … Continue reading

Posted in Affordable Care Act, budget cuts, consumer protection, Health Care Reform, seniors, technology and pharmaceutical costs | Tagged , , , , | Leave a comment

Pharmaceutical costs–what’s behind them

I have been recovering from my hip replacement surgery with a few post surgical complications from another ailment.  That said, I could not resist sharing this link from the Kaiser Family Foundation news service. They are a 501© 3 non-profit … Continue reading

Posted in consumer protection, pharmaceutical companies, prescription drugs, technology and pharmaceutical costs, Uncategorized | Tagged , , , , , , | Leave a comment

The American Health Care Machine and You: A Call to Conscience– $40 million executive bonus and what $40 million could cover

 Health care is a top issue in the presidential race, but unmentioned is the $40. 2 million Golden Parachute for Humana’s CEO if the proposed merger with Aetna is approved.  “Humana CEO Bruce Broussard is primed for a huge payday. … Continue reading

Posted in Affordable Care Act, aging, budget cuts, community action, consumer protection, Economy, Health Care Reform, health care stories, health insurance, hospitals, long-term care, Medicare, patient care, patients' voice, policy and politics, public dialogue, technology and pharmaceutical costs | Tagged , , , , , , , , , , , , , , , , , , | Leave a comment

See How America’s Health Care Costs and Outcomes Compare to Others

I have been busy on a project and not blogging as frequently.  Given the discussions about health care in the election, however, I thought people would find this brief graphic video by the Kaiser Family Foundation of interest.  It shows … Continue reading

Posted in Affordable Care Act, Economy, Health Care Reform, health insurance, patient safety, policy and politics, politics, prescription drugs, public dialogue, quality of care, technology and pharmaceutical costs | Tagged , , , , , , , , , , , , , , , , , , | Leave a comment

Congress Tackles Drug Prices: Much Bipartisan Support; and Recent Trends in Drug Costs Here and What Other Countries Pay

Finally it looks like Congress might just re-visit Medicare Part D and let Medicare negotiate rates with drug companies.   See charts below: http://www.statnews.com/2015/12/01/stat-harvard-drug-prices-poll/  The VA and Medicaid can negotiate rates. Senate Special Committee on Aging holds drug costs hearing December … Continue reading

Posted in aging, Economy, media, Medicare, pharmaceutical companies, policy and politics, politics, prescription drugs, technology and pharmaceutical costs | Tagged , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Drug Costs and Congress: Investments, Contributions and You

A scathing new article on Congress and its financial conflicts of interests with drug and device companies appears in STAT, a news firm specializing in health and science. It examines Senators and Representatives who have oversight of the FDA and … Continue reading

Posted in health insurance, medical bankruptcy, Medicare, pharmaceutical companies, policy and politics, prescription drugs, public dialogue, technology and pharmaceutical costs | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

What You CAN Do About Prescription Drug Costs

What American’s Think About Prices and What You Can Do                      “Corporations now spend at least $2.6 billion a year lobbying Congress—more than the $2 billion taxpayers spend funding the House and the Senate.”  The Week, July 31, 2015 What … Continue reading

Posted in consumer protection, Economy, health insurance, medical bankruptcy, Medicare, patients' voice, policy and politics, technology and pharmaceutical costs | Tagged , , , , , , , , , , , , , , , , | Leave a comment

Did You Know? New Series on Long-term Care. PART I: Medicare Can’t Negotiate Drug Prices—VA and Medicaid Can

The Presidential election season is once again upon us.  The Affordable Care Act deals with some Medicare issues, but some key ones are not addressed. Pharmaceutical costs and long-term care are two of them.  Here is a question you can … Continue reading

Posted in business, consumer protection, Health Care Reform, medical bankruptcy, Medicare, patients' voice, policy and politics, technology and pharmaceutical costs | Tagged , , , , , , , , , , , , , | Leave a comment

“IT Depends”–Why America’s Health Care IS All Dollars and No Sense–And What YOU Can Do

 Why America’s Health Care is All Dollars and No Sense and What You Can Do © (excerpt–page 5)   “A Clear Concise Guide to America’s Health Care” Health Care is foreign territory. Unlike foreign countries there is no embassy or safe … Continue reading

Posted in Health Care Reform, patients' voice, technology and pharmaceutical costs | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

The Buck STILL Stops Nowhere–order now–Here’s Why; Coming Next–Big Changes for Hospitals

The Buck Still Stops Nowhere If you ever wondered why you must read the new The Buck Still Stops Nowhere, just read the stories below.  Open the link and scroll down to related stories on pre-existing conditions and other attempts to get around … Continue reading

Posted in consumer protection, Health Care Reform, health insurance, hospitals, medical bankruptcy, Medicare, patients' voice, policy and politics, technology and pharmaceutical costs | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment